NCT00219271View on ClinicalTrials.gov

Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Prostate Cancer
Interventions
DRUG

Zoledronic acid

Trial Locations (1)

Unknown

Novartis Investigative Site, Athens

Sponsors
All Listed Sponsors
collaborator

University of Athens

OTHER

lead

Novartis Pharmaceuticals

INDUSTRY